Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02263495 |
|---|---|
| Brief Title: | Eribulin Plus Gemcitabine (EG) vs Paclitaxel Plus Gemcitabine (PG) in HER2-Negative Metastatic Breast Cancer (EG_PG) |
| First Submitted : | October 6, 2014 |
| First Submitted that Met QC Criteria : | October 10, 2014 |
| First Posted : | October 13, 2014 (Estimate) |
| Last Update Submitted that Met QC Criteria : | July 12, 2020 |
| Last Update Posted : | July 14, 2020 |